This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Xu M, Wang B, Fu Y, Chen Y, Yang F, Lu H, Li L. Changes of fecal Bifidobacterium species in adult patients with Hepatitis B virus-induced chronic liver disease. Microb Ecol. 2012; 63: 304–313.XuMWangBFuYChenYYangFLuHLiLChanges of fecal Bifidobacterium species in adult patients with Hepatitis B virus-induced chronic liver disease201263304313Search in Google Scholar
Maukonen J, Kolho KJ, Paasela M, Honkanen J, Klemetti P, Vaarala O, Saarela M. Altered fecal mikrobiota in paediatric inflammatory bowel disease. J Crohns Colitis. 2015; 9: 1088–1095.MaukonenJKolhoKJPaaselaMHonkanenJKlemettiPVaaralaOSaarelaMAltered fecal mikrobiota in paediatric inflammatory bowel disease2015910881095Search in Google Scholar
Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, Akkermans LM. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol. 2009; 15: 2887–2892.KerckhoffsAPSamsomMvan der RestMEde VogelJKnolJBen-AmorKAkkermansLMLower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients20091528872892Search in Google Scholar
Golfetto L, de Senna FD, Hermes J, Beserra BT, França FD, Martinello F. Lower Bifidobacteria counts in adult patients with celiac disease on a gluten-free diet. Arq. Gastroenterol. 2014; 51: 139–143.GolfettoLde SennaFDHermesJBeserraBTFrançaFDMartinelloFLower Bifidobacteria counts in adult patients with celiac disease on a gluten-free diet201451139143Search in Google Scholar
De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Francavilla R. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS ONE. 2013; 8: e76993.De AngelisMPiccoloMVanniniLSiragusaSDe GiacomoASerrazzanettiDIFrancavillaRFecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified20138e76993Search in Google Scholar
Amabebe E, Robert FO, Agbalalah T, Orubu ESF. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr. 2020; 123: 1127–1137.AmabebeERobertFOAgbalalahTOrubuESFMicrobial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism202012311271137Search in Google Scholar
Tojo R. Intestinal microbiota in health and disease Role of bifidobacteria in gut homeostasis. World J. Gastroenterol. 2014; 20: 15163.TojoRIntestinal microbiota in health and disease Role of bifidobacteria in gut homeostasis20142015163Search in Google Scholar
Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol. 2020; 16: 571731.ScheithauerTPMRampanelliENieuwdorpMVallanceBAVerchereCBvan RaalteDHHerremaHGut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes202016571731Search in Google Scholar
Gosiewski T, Salamon D, Szopa M, Sroka A, Malecki MT, Bulanda M. Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes - A pilot study. Gut Pathog. 2014; 6: 43.GosiewskiTSalamonDSzopaMSrokaAMaleckiMTBulandaMQuantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes - A pilot study2014643Search in Google Scholar
Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, Shulzhenko N. Role of gut microbiota in type 2 diabetes pathophysiology. eBioMedicine. 2020; 51: 496.GurungMLiZYouHRodriguesRJumpDBMorgunAShulzhenkoNRole of gut microbiota in type 2 diabetes pathophysiology202051496Search in Google Scholar
Krawczyk A, Salamon D, Kowalska-Duplaga K, Bogiel T, Gosiewski T. Association of fungi and archaea of the gut microbiota with Crohn’s disease in pediatric patients-pilot study. Pathogens. 2021; 10: 1119.KrawczykASalamonDKowalska-DuplagaKBogielTGosiewskiTAssociation of fungi and archaea of the gut microbiota with Crohn’s disease in pediatric patients-pilot study2021101119Search in Google Scholar
Salamon D, Gosiewski T, Krawczyk A, Sroka-Oleksiak A, Duplaga M, Fyderek K, Kowalska-Duplaga K. Quantitative changes in selected bacteria in the stool during the treatment of Crohn’s disease. Adv. Med. Sci. 2020; 65: 348–353.SalamonDGosiewskiTKrawczykASroka-OleksiakADuplagaMFyderekKKowalska-DuplagaKQuantitative changes in selected bacteria in the stool during the treatment of Crohn’s disease202065348353Search in Google Scholar
Matsuki T, Watanabe K, Fujimoto J, Takada T, Matsumoto K, Kado Y. Quantitative PCR with 16S primers for analysis of human intestinal bifidobacteria. Appl. Environ. Microbiol. 2004; 70:167–173.MatsukiTWatanabeKFujimotoJTakadaTMatsumotoKKadoYQuantitative PCR with 16S primers for analysis of human intestinal bifidobacteria200470167173Search in Google Scholar
Sinclair L, Osman OA, Bertilsson S, Eiler A. Microbial community composition and diversity via 16S rRNA gene amplicons: Evaluating the illumina platform. PLoS ONE. 2015; 10: e0116955.SinclairLOsmanOABertilssonSEilerAMicrobial community composition and diversity via 16S rRNA gene amplicons: Evaluating the illumina platform201510e0116955Search in Google Scholar
Le KA, Li Y, Xu X, Yang W, Liu T, Zhao X, Hui H. Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population. Front. Physiol. 2013;3: 496.LeKALiYXuXYangWLiuTZhaoXHuiHAlterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population20133496Search in Google Scholar
Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X, Yu P, Zhao C, Li L, Zhou A, et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol. 2010; 61: 69–78.WuXMaCHanLNawazMGaoFZhangXYuPZhaoCLiLZhouAMolecular characterisation of the faecal microbiota in patients with type II diabetes2010616978Search in Google Scholar
Shillitoe E, Weinstock R, Kim T, Simon H, Planer J, Noonan S, Cooney R. The oral microflora in obesity and type-2 diabetes. J. Oral Microbiol. 2012; 4: 19013.ShillitoeEWeinstockRKimTSimonHPlanerJNoonanSCooneyRThe oral microflora in obesity and type-2 diabetes2012419013Search in Google Scholar
Allin KH, Nielsen T, Pedersen O. Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus. Eur J Endocrinol. 2015; 172: 167–177.AllinKHNielsenTPedersenOMechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus2015172167177Search in Google Scholar
Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M. The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis. 2016; 15: 108.BaothmanOAZamzamiMATaherIAbubakerJAbu-FarhaMThe role of gut microbiota in the development of obesity and diabetes201615108Search in Google Scholar
Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004; 25: 4–7.DandonaPAljadaABandyopadhyayAInflammation: the link between insulin resistance, obesity and diabetes20042547Search in Google Scholar
Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, Queipo-Ortuño MI. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 2013; 11: 46.MurriMLeivaIGomez-ZumaqueroJMTinahonesFJCardonaFSoriguerFQueipo-OrtuñoMIGut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study20131146Search in Google Scholar
Wang J, Qin J, Li Y, Cai Z, Li S, Zhu J, Wang J. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490: 55–60.WangJQinJLiYCaiZLiSZhuJWangJA metagenome-wide association study of gut microbiota in type 2 diabetes20124905560Search in Google Scholar
De Goffau MC, Fuentes S, van den Bogert B, Honkanen H, de Vos WM, Welling GW, Hyöty H, Harmsen HJ. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia. 2014; 57: 1569–1577.De GoffauMCFuentesSvan den BogertBHonkanenHde VosWMWellingGWHyötyHHarmsenHJAberrant gut microbiota composition at the onset of type 1 diabetes in young children20145715691577Search in Google Scholar
Soyucen E, Gulcan A, Aktuglu-Zeybek AC, Onal H, Kiykim E, Aydin A. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatrics International., 2014; 56: 336–343.SoyucenEGulcanAAktuglu-ZeybekACOnalHKiykimEAydinADifferences in the gut microbiota of healthy children and those with type 1 diabetes201456336343Search in Google Scholar
Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: Stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr. 2009; 101: 541–50.Ramirez-FariasCSlezakKFullerZDuncanAHoltropGLouisPEffect of inulin on the human gut microbiota: Stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii200910154150Search in Google Scholar
Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuño MI. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol. 2014; 5: 190.Moreno-IndiasICardonaFTinahonesFJQueipo-OrtuñoMIImpact of the gut microbiota on the development of obesity and type 2 diabetes mellitus20145190Search in Google Scholar
Wang G, Si Q, Yang S, Jiao T, Zhu H, Tian P, Wang L, Li X, Gong L, Zhao J, et al. Lactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners. Food Funct. 2020; 11: 5898–5914.WangGSiQYangSJiaoTZhuHTianPWangLLiXGongLZhaoJLactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners20201158985914Search in Google Scholar
Akbari V, Hendijani F. Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis. Nutr Rev. 2016; 74: 774–784.AkbariVHendijaniFEffects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis201674774784Search in Google Scholar
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444: 1022–1023.LeyRETurnbaughPJKleinSGordonJIMicrobial ecology: human gut microbes associated with obesity200644410221023Search in Google Scholar
Marlicz W, Ostrowska L, Łoniewski I. Intestinal microbiota and its potential relationship with obesity. Endokrynol Otył Zab Przem Mat. 2013; 9: 20–28.MarliczWOstrowskaLŁoniewskiIIntestinal microbiota and its potential relationship with obesity201392028Search in Google Scholar
Gong H, Gao H, Ren Q, He J. The abundance of bifidobacterium in relation to visceral obesity and serum uric acid. Sci Rep. 2022; 12: 13073.GongHGaoHRenQHeJThe abundance of bifidobacterium in relation to visceral obesity and serum uric acid20221213073Search in Google Scholar
Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004; 101: 15718–15723.BäckhedFDingHWangTHooperLVKohGYNagyASemenkovichCFGordonJIThe gut microbiota as an environmental factor that regulates fat storage20041011571815723Search in Google Scholar
Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Hostbacterial mutualism in the human intestine. Science. 2005; 307: 1915–1920.BäckhedFLeyRESonnenburgJLPetersonDAGordonJIHostbacterial mutualism in the human intestine200530719151920Search in Google Scholar
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444: 1027–1031.Table 2TurnbaughPJLeyREMahowaldMAMagriniVMardisERGordonJIAn obesity-associated gut microbiome with increased capacity for energy harvest200644410271031Table 2Search in Google Scholar